All News


 

2020

June

Media Release / Jun 09, 2020

Sandoz Canada receives Health Canada approval to launch two oncology biosimilars: Ziextenzo® and Riximyo®

Read More

April

Media Release / Apr 27, 2020

Novartis in Canada, including Sandoz Canada, initiates Community Strong COVID-19 response program

Read More
2019

July

Media Release / Jul 10, 2019

Novartis in Canada, including Sandoz Canada, proud to be Great Place to Work certified!

Read More

June

Media Release / Jun 12, 2019

Sandoz Canada launches PrHydrocortisone cream 2.5%

Read More

May

Media Release / May 27, 2019

BC PharmaCare’s Biosimilars Initiative an important step towards improving patient access to safe and effective medicines

Read More
Media Release / May 20, 2019

British Columbia adds Erelzi® (etanercept) to its PharmaCare drug plan for the treatment of psoriatic arthritis (PsA) in adult patients

Read More

January

Media Release / Jan 30, 2019

Sandoz Canada remains among Top Employers in Montreal and gains new Top Employer Canada certification for 2019

Read More
Media Release / Jan 21, 2019

New indication approved for Sandoz Erelzi® (etanercept) in the Treatment of Psoriatic Arthritis

Read More
2018

August

Media Release / Aug 15, 2018

Sandoz Canada Statement about Ontario Cannabis Announcement

Read More

June

Media Release / Jun 19, 2018

Sandoz Canada Becomes the First Canadian Pharmaceutical Company to Enter the Medical Cannabis Field

Read More